Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Hooman Motahari's research centers on the intersection of thyroid function, mental health, and public health considerations. His work includes a systematic review and meta-analysis investigating the association between thyroid function and suicidal behavior. Motahari has also explored the discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism, conducting a pilot randomized clinical trial on its feasibility. Other research interests include the impact of biotin supplementation on diagnostic accuracy for adrenal insufficiency and a case study on diabetic ketoacidosis associated with alpelisib. He has also contributed to understanding the thyroid status of patients with COVID-19, noting that most are euthyroid. Motahari collaborates with several researchers at the University of Arkansas for Medical Sciences, including Soumya Thumma, Spyridoula Maraka, Lakshmi Menon, and Richard R. Owen, with whom he has co-authored multiple publications.
Metrics
- h-index: 6
- Publications: 12
- Citations: 417
Selected Publications
-
Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial (2025)
-
THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial (2023)
-
Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis (2021)
-
Biotin Supplementation Creates the Misleading Diagnosis of Secondary Adrenal Insufficiency (2021)
-
A Case of Diabetic Keto Acidosis From Alpelisib (2021)
-
Most Patients with COVID-19 Are Euthyroid (2021)
Collaboration Network
Top Collaborators
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Biotin Supplementation Creates the Misleading Diagnosis of Secondary Adrenal Insufficiency
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- A Case of Diabetic Keto Acidosis From Alpelisib
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Most Patients with COVID-19 Are Euthyroid
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Biotin Supplementation Creates the Misleading Diagnosis of Secondary Adrenal Insufficiency
- A Case of Diabetic Keto Acidosis From Alpelisib
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- A Case of Diabetic Keto Acidosis From Alpelisib
Similar Researchers
Based on overlapping research topics